Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
OLMESARTAN GxP, OLMESARTAN GPPL, OLMES, OLMESART (Generic Partners Pty Ltd)
Product name
OLMESARTAN GxP, OLMESARTAN GPPL, OLMES, OLMESART
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
138 working days (255)
Active ingredients
olmesartan medoxomil
Registration type
New generic medicine
Indication
OLMESARTAN GxP, OLMESARTAN GPPL, OLMES, OLMESART (tablets) is indicated for the treatment of hypertension.